Daedong Hospital Achieves Grade 1 in Dementia Appropriateness Evaluation by Health Insurance Review and Assessment Service

Daedong Hospital.

[Asia Economy Yeongnam Reporting Headquarters Reporter Hwang Du-yeol] Daedong Hospital recently received a Grade 1 rating in the 1st Dementia Adequacy Evaluation announced by the Health Insurance Review and Assessment Service.

With the aging population causing an increase in dementia patients and medical expenses each year, the Health Insurance Review and Assessment Service conducted the dementia adequacy evaluation for the first time this year to ensure that dementia patients receive accurate diagnosis and treatment early on and access high-quality dementia medical services.

This evaluation targeted dementia patients who were prescribed dementia medication for the first time in outpatient clinics over six months starting from October 2021, assessing 889 institutions nationwide including tertiary general hospitals, general hospitals, and hospitals.

The evaluation criteria included ▲ the proportion of attending physicians who are neurologists, psychiatrists, or doctors who have completed dementia-related training ▲ the rate of structural brain imaging tests for dementia diagnosis ▲ the rate of essential blood tests for dementia diagnosis ▲ the rate of screening and scale tests for dementia diagnosis, among others.

A total of 223 medical institutions, accounting for 25.1%, received Grade 1, and in Busan, 21 institutions including Daedong Hospital were selected.

Moon In-su, head of the Neurology Department at Daedong Hospital, said, “Dementia, a chronic degenerative disease, causes significant difficulties in daily life due to various impairments such as memory, thinking, language, and personality. It is important to receive appropriate treatment early to delay symptom worsening. We will continue to strive to ensure that dementia patients in our region receive high-quality medical services.”

Daedong Hospital also received Grade 1 ratings in adequacy evaluations for acute stroke, pneumonia, chronic obstructive pulmonary disease, hemodialysis, anesthesia, and blood transfusion from the Health Insurance Review and Assessment Service.

This content was produced with the assistance of AI translation services.